Asthma

An inflammatory condition of the airways, asthma typically presents during childhood. It is very common, and affects hundreds of millions of people worldwide. Asthma is often

...


Read more on Asthma

 

 

Latest news articles

Added 1 month ago Drug news

CHMP recommends approval for Dupixent for add-on maintenance treatment for severe asthma

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent (dupilumab),...

Added 2 months ago Drug news

FDA approves first generic Advair Diskus to treat asthma and COPD.- Mylan

The FDA has approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment...

Added 3 months ago Drug news

NICE recommends use of Fasenra in eosinophilic asthma.- AstraZeneca.

The National Institute for Health and Care Excellence has recommended that Fasenra (benralizumab), from AstraZeneca, be available to people with...

Search all news articles for Asthma
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Allergic Rhinitis

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

+ 4 more

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.

+ 7 more

Load more

Guidelines

Asthma: diagnosis, monitoring and chronic asthma management

This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks.

Added 10 months ago

British Guideline on the Management of Asthma

The 2016 update includes a complete revision of the section on diagnosis of asthma and a major update to the section on pharmacological management of asthma as well as revisions to the sections on supported self management...

Added 4 years ago

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

The present guideline was developed on behalf of and financed by the German Society for Allergology and Clinical Immu-nology (Deutsche Gesellschaft für Allergologie und klinische Immunologie, DGAKI)...

Added 2 years ago

Search all guidelines for Asthma
 

Journal articles

As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.

Background: Patients with mild asthma often rely on inhaled short-acting β2-agonists for symptom relief and have poor adherence to maintenance therapy.

Added 9 months ago

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.

Dupilumab is a fully human anti-interleukin-4 receptor α monoclonal antibody that blocks both interleukin-4 and interleukin-13 signaling. Its effectiveness in reducing oral glucocorticoid use in patients with severe asthma while...

Added 9 months ago

Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies.

Background: Benralizumab is an anti-eosinophilic, anti-interleukin-5 receptor α monoclonal antibody that has been shown to significantly reduce asthma exacerbations and improve lung function for patients with...

Added 1 year ago

Search all journal articles for Asthma
 

Clinical trials

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma (VENTURE)

Primary Objective:
- To evaluate the efficacy of dupilumab, compared with placebo, for reducing the use of maintenance oral corticosteroids (OCS) in patients with severe steroid-dependent asthma.

Added 1 year ago

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

Primary Objective:
- To evaluate the efficacy of dupilumab (SAR231893 / REGN668) in patients with persistent asthma.

Added 1 year ago

Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma (TROPOS)

A Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Reducing Oral Corticosteroid dependent Asthma.

Added 1 year ago

Search all clinical trials for Asthma
 
The Asthma Report

The Asthma Report brings you the latest respiratory news from international congresses and scientific meetings.

ERS 2018 | Day 5 Highlights

The Asthma Report wraps up from Paris, with our final report from ERS Congress 2018.

 

CME

Respiratory care clinical Q&A November 2015

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Management of acute cough in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Easily missed: Occupational asthma

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
0
Registration required
1
Subscription fee
89
Search all CME for Asthma